CXCL9 and neoplasm: Added to this, there is the further complexity of tumours using epigenetic silencing to switch off production of Th1-based chemokines such as CXCL9 and CXCL10, a novel immune escape mechanism employed by tumours to reduce infiltration by cytotoxic effector cells [35].